SYRE filings
Corporate insider profile
Tomas Kiselak Filing Activity
Latest reported as Corporate insider of Spyre Therapeutics, Inc. (SYRE).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$399,658,667.11
- Latest transaction
- Jun 23, 2026
Affiliated corporations
Reported company relationships
Transaction history
